首页 › 基金 › Birchview Capital, LP › SLGL
Birchview Capital, LP 对 SLGL 的持仓历史
SOL-GEL TECHNOLOGIES LTD · 医疗保健
Birchview Capital, LP 在 Q3 2026 的 13F 申报中披露持有 SLGL(SOL-GEL TECHNOLOGIES LTD)7,600 股,市值约 US$565K,约占其申报组合的 0.34%,在其申报持仓中市值排名第 47 位。 Birchview Capital, LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Birchview Capital, LP 对 SLGL 的持仓演变
Birchview Capital, LP 于 Q3 2026 首次披露 SLGL 持仓:7,600 股(约 US$565K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 7.60K | $564.53K | 新进 |
关于 SLGL 与 13F 数据
SLGL(SOL-GEL TECHNOLOGIES LTD)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 SLGL,申报仓位最大的包括:Opaleye Management Inc. (US$37.1M), GREAT POINT PARTNERS LLC (US$20.3M), Trails Edge Capital Partners, LP (US$10.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SLGL 的基金
- Opaleye Management Inc. 500.00K 股 · $37.07M · Q2 2026
- GREAT POINT PARTNERS LLC 274.36K 股 · $20.34M · Q2 2026
- Trails Edge Capital Partners, LP 139.44K 股 · $10.34M · Q2 2026
- Squadron Capital Management LLC 52.00K 股 · $3.86M · Q2 2026
更多关于 Birchview Capital, LP
常见问题
How long has Birchview Capital, LP held SLGL?
Birchview Capital, LP has disclosed SLGL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Birchview Capital, LP's current position in SLGL?
As of Q3 2026, Birchview Capital, LP holds 7.60K shares of SLGL (SOL-GEL TECHNOLOGIES LTD), valued at $564.53K, representing 0.34% of its reported portfolio and ranking #47.
Has Birchview Capital, LP been buying or selling SLGL?
In the latest 13F filing (Q3 2026), Birchview Capital, LP newly opened its position in SLGL.
Which other funds hold SLGL?
Other major institutional holders of SLGL include Opaleye Management Inc., GREAT POINT PARTNERS LLC, Trails Edge Capital Partners, LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.